Attitudes of health care workers toward COVID-19 vaccination: A literature review
Abstract
One of the main goals of current COVID-19 vaccination programs is to achieve herd immunity, which would inhibit further spread of the virus. However, achieving this goal is impossible without widespread public acceptance of vaccination. As a result, concerns about the decision to accept vaccination have become a key public health challenge on a global scale in recent years. Healthcare workers’ attitudes toward COVID-19 vaccination are mostly related to accepting vaccine preparations and recommending them to patients. This is of great importance for maintaining the continuity of health care, as it contributes to protecting medical workers from SARS-CoV-2 virus infection and thus counteracts their absenteeism. In turn, with an adequate number of employees in healthcare facilities, it is possible to provide proper care to patients in a life- or health-threatening condition. In addition, medics are often considered authorities on health issues. Therefore, their trust and submission to vaccination will positively influence the public and encourage them to undergo the COVID-19 vaccination.
References
WHO coronavirus (COVID-19) dashboard. Available online: https://covid19.who.int/ (accessed on 2 November 2023).
Coronavirus infection report (SARS-CoV-2) (Polish). Available online: https://www.gov.pl/web/koronawirus/wykaz-zarazen-koronawirusem-SARS-CoV-2 (accessed on 2 November 2023).
Robillard R, Saad M, Edwards J, et al. Social, financial and psychological stress during an emerging pandemic: Observations from a population survey in the acute phase of the COVID-19. British Medical Journal 2020; 10: e043805. doi: 10.1136/bmjopen-2020-043805
Catching A, Capponi S, Yeh MT, et al. Examining the interplay between face mask usage, asymptomatic transmission, and social distancing on the spread of the COVID-19. Scientific Reports 2021; 11: 15998. doi: 10.1038/s41598-021-94960-5
Durmuş H, Gökler ME, Metintaş S. The effectiveness of community-based social distancing for mitigating the spread of the COVID-19 pandemic in Turkey. Journal of Preventive Medicine & Public Health 2020; 53(6): 397–404. doi: 10.3961/jpmph.20.381
Salmon DA, Dudley MZ, Brewer J, et al. COVID-19 vaccination attitudes, values, and intentions among United States adults before emergency use authorization. Vaccine 2021; 39(19): 2698–2711. doi: 10.1016/j.vaccine.2021.03.034
Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine 2020; 38(42): 6500–6507. doi: 10.1016/j.vaccine.2020.08.043
Bailey RI, Cheng HH, Chase-Topping M, et al. Pathogen transmission from vaccinated hosts can cause a dose-dependent reduction in virulence. PLoS Biology 2020; 18(3): e3000619. doi: 10.1371/journal.pbio.3000619
Koontalay A, Suksatan W, Prabsangob K, Sadang JM. Healthcare workers’ burdens during the COVID-19 pandemic: A qualitative systematic review. Journal of Multidisciplinary Healthcare 2021; 14: 3015–3025. doi: 10.2147/JMDH.S330041
Ardebili ME, Naserbakht M, Bernstein C, et al. Healthcare provider’s experience of working during the COVID-19 pandemic: A qualitative study. American Journal of Infection Control 2021; 49(5): 547–554.
Abbas AK, Lichtman AH, Pillai S. Basic Immunology: Functions and Disorders of the Immune System, 7th ed. Elsevier; 2023. 352p.
Steele A (editor). Immunology: Functions and Disorders of the Immune System. States Academic Press; 2022. 241p.
Summary—COVID-19 vaccine: About the disease (Polish). Available online: https://szczepienia.pzh.gov.pl/szczepionki/covid-19-2/ (accessed on 2 November 2023).
Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. The New England Journal of Medicine 2020; 383: 2603–2615. doi: 10.1056/NEJMoa2034577
Ndwandwe D, Wiysonge CS. COVID-19 vaccines. Current Opinion in Immunology 2021; 71: 111–116. doi: 10.1016/j.coi.2021.07.003
Rappuoli R, De Gregorio E, Del Giudice G, et al. Vaccinology in the post−COVID-19 era. Proceedings of the National Academy of Sciences 2021; 118(3): e2020368118. doi: 10.1073/pnas.2020368118
Gao Q, Bao L, Mao H, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science 2020; 369: 77–81. doi: 10.1126/science.abc1932
Sanders B, Koldijk M, Schuitemaker H. Inactivated viral vaccines. In: Nunnally B, Turula V, Sitrin R (editors). Vaccine Analysis: Strategies, Principles, and Control. Springer; 2015.
Okamura S, Ebina H. Could live attenuated vaccines better control COVID-19? Vaccine 2021; 39(39): 5719–5726. doi: 10.1016/j.vaccine.2021.08.018
Wong LA, Yap CG, Jahan NK, Pillai N. COVID-19 vaccine: Review of the mechanism of action of different types of vaccine. Open Access Library Journal 2022; 9(4): 1–20. doi: 10.4236/oalib.1108624
Kushnir A, Mueller S, Tasker S, Robert Coleman J. 577. COVI-VAC™, a live attenuated COVID-19 vaccine, provides single dose protection against heterologous challenge with SARS-CoV-2 beta (B.1.351) in the Syrian golden hamster model. Open Forum Infectious Diseases 2021; 8(Supplement_1): S390. doi: 10.1093/ofid/ofab466.775
Peng XL, Cheng JSY, Gong HL, et al. Advances in the design and development of SARS-CoV-2 vaccines. Military Medical Research 2021; 8: 67. doi: 10.1186/s40779-021-00360-1
Mendonça SA, Lorincz R, Boucher P, et al. Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic. NPJ Vaccines 2021; 6(1). doi: 10.1038/s41541-021-00356-x
Yang J, Wang W, Chen Z, et al. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature 2020; 586(7830): 572–577. doi: 10.1038/s41586-020-2599-8
Parums DV. Editorial: First approval of the protein-based adjuvanted Nuvaxovid (NVX-CoV2373) Novavax vaccine for SARS-CoV-2 could increase vaccine uptake and provide immune protection from viral variants. Medical Science Monitor 2022; 28: e936523. doi: 10.12659/msm.936523
Vitiello A, Ferrara F. Brief review of the mRNA vaccines COVID-19. Inflammopharmacology 2021; 29(3): 645–649. doi: 10.1007/s10787-021-00811-0
Shekhar R, Sheikh AB, Upadhyay S, et al. COVID-19 vaccine acceptance among health care workers in the United States. Vaccines 2021; 9(2): 119. doi: 10.3390/vaccines9020119
Globevnik Velikonja V, Verdenik I, Erjavec K, et al. Influence of psychological factors on vaccination acceptance among health care workers in Slovenia in three different phases of the COVID-19 pandemic. Vaccines 2022; 10(12): 1983. doi: 10.3390/vaccines10121983
Spitzer RL, Kroenke K, Williams JBW, et al. A brief measure for assessing generalized anxiety disorder. Archives of Internal Medicine 2006; 166(10): 1092. doi: 10.1001/archinte.166.10.1092
Al-Sanafi M, Sallam M. Psychological determinants of the COVID-19 vaccine acceptance among healthcare workers in Kuwait: A cross-sectional study using the 5C and vaccine conspiracy beliefs scales. Vaccines 2021; 9(7): 701. doi: 10.3390/vaccines9070701
Betsch C, Schmid P, Heinemeier D, et al. Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PLoS One 2018; 13(12): e0208601. doi: 10.1371/journal.pone.0208601
Shapiro GK, Holding A, Perez S, et al. Validation of the vaccine conspiracy beliefs scale. Papillomavirus Research 2016; 2: 167–172. doi: 10.1016/j.pvr.2016.09.001
Verger P, Scronias D, Dauby N, et al. Attitudes of healthcare workers towards COVID-19 vaccination: A survey in France and French-speaking parts of Belgium and Canada, 2020. Eurosurveillance 2021; 26(3): 2002047. doi: 10.2807/1560-7917.es.2021.26.3.2002047
Copyright (c) 2023 Daria Łaskawiec-Żuławińska, Marika Wlazło, Mateusz Grajek, Ilona Korzonek-Szlacheta
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors contributing to this journal agree to publish their articles under the Creative Commons Attribution 4.0 International License, allowing third parties to share their work (copy, distribute, transmit) and to adapt it for any purpose, even commercially, under the condition that the authors are given credit. With this license, authors hold the copyright.
